(Bloomberg) — The Trump administration is planning a Manhattan Project-style program to drastically cut the time it takes to develop a coronavirus vaccine. Gilead Sciences Inc. said its experimental treatment remdesivir helped patients recover faster, sending U.S. stocks higher.New York reported a fourth day of declining deaths and is ramping up testing as it moves toward reopening some regions. France and Spain took cautious steps toward lifting restrictions.U.S. economic data showed the country’s record-long expansion is over, with a recession under way. Japan’s industrial production fell less than expected in March but much steeper declines are likely ahead as a …read more
Source:: Yahoo Finance
